Joyce Massengill

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites

Marguerite A. Butler, Nicholas P. Lang, J.F. Young et al. · Pharmacogenetics · 1992 · 418 citations

Chemoprevention Strategy, Human Populations, Metabolomic Profiling +19

Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.

Nicholas P. Lang, Marguerite A. Butler, Joyce Massengill et al. · PubMed · 1994 · 392 citations

Chemoprevention Strategy, Metabolomic Profiling, Pathology +17

The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans

Michael Malfatti, Kristen S. Kulp, Mark G. Knize et al. · Carcinogenesis · 1999 · 100 citations

Determination of Carcinogenic Arylamine N-Oxidation Phenotype in Humans by Analysis of Caffeine Urinary Metabolites

Marguerite A. Butler, Nicholas P. Lang, John F. Young et al. · 1990 · 27 citations

Caffeine Urinary Metabolites, Biochemistry, Medicine +11

In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

Nicholas P. Lang, Susan Nowell, Michael Malfatti et al. · Cancer Letters · 1999 · 26 citations

Energy Metabolism, Biochemistry, Vivo Human Metabolism +5